Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Sodium Starch Glycolate Market Analysis

ID: MRFR/CnM/4315-HCR
100 Pages
Anshula Mandaokar
March 2026

Sodium Starch Glycolate Market information: by product (potato, corn, wheat, and others), by application (pharmaceuticals, food ingredients, adhesives, textile, and others), and by region- Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Sodium Starch Glycolate Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Sodium Starch Glycolate Market Industry Landscape

The Sodium Starch Glycolate (SSG) Market is influenced by various market dynamics that shape its growth trajectory and competitive landscape. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and make informed decisions.

1. Pharmaceutical Industry Growth: The pharmaceutical industry's expansion is a primary driver for the Sodium Starch Glycolate market. SSG is widely used as a superdisintegrant in pharmaceutical formulations to enhance drug dissolution and bioavailability. With the rising demand for pharmaceutical products globally, the need for effective disintegrants like SSG is increasing, driving market growth.

2. Increased Focus on Generic Drugs: The growing emphasis on generic drugs, driven by cost-effectiveness and patent expirations of branded medications, is fueling demand for SSG. Generic drug manufacturers utilize SSG as a key ingredient in tablet formulations to achieve rapid disintegration and drug release, replicating the performance of branded counterparts. This trend is expected to sustain market growth as the generic drug market continues to expand.

3. Technological Advancements in Formulation Development: Technological advancements in formulation development are influencing the Sodium Starch Glycolate market dynamics. Pharmaceutical companies are investing in research and development to create innovative drug formulations with improved efficacy and patient compliance. SSG manufacturers are innovating to provide specialized grades of SSG tailored to specific formulation requirements, driving product differentiation and market competitiveness.

4. Regulatory Compliance and Quality Standards: Stringent regulatory compliance and adherence to quality standards play a crucial role in shaping the Sodium Starch Glycolate market. Pharmaceutical manufacturers must meet regulatory requirements related to drug safety, efficacy, and quality during formulation development. SSG suppliers need to ensure product consistency, purity, and compliance with pharmacopeial standards to gain regulatory approvals and maintain market credibility.

5. Demand for Plant-Based Excipients: Growing consumer preference for plant-based and natural ingredients in pharmaceutical formulations is impacting the SSG market dynamics. Sodium Starch Glycolate, derived from potato or corn starch, aligns with this trend as a plant-based excipient. Manufacturers are capitalizing on the demand for natural ingredients by promoting the use of SSG as a reliable and sustainable option in pharmaceutical formulations, driving market growth.

6. Supply Chain Disruptions and Raw Material Availability: The Sodium Starch Glycolate market is susceptible to supply chain disruptions and raw material availability challenges. SSG production relies on a steady supply of starch-based raw materials such as potato or corn starch. Any fluctuations in raw material availability or disruptions in the supply chain can impact SSG production and lead to price volatility, affecting market dynamics.

7. Regional Market Dynamics: Regional market dynamics, influenced by factors such as healthcare infrastructure, regulatory environment, and pharmaceutical industry trends, also impact the Sodium Starch Glycolate market. Emerging economies with a growing pharmaceutical sector present lucrative opportunities for market expansion, while mature markets demand high-quality SSG products compliant with stringent regulations, driving market segmentation and specialization.

Author
Author Profile
Anshula Mandaokar
Team Lead - Research

Anshula Mandaokar holds an academic degree in Chemical Engineering and has been contributing to the field for more than 5 years. She has expertise in Market Research and Business Consulting and serves as a Team Lead for a reputed Market Research firm under the Chemicals and Materials domain spectrum. She has worked on multiple projects, generating explicit results in a quick turnaround time. Her understanding of data interpretation justifies her role as a leader.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Sodium Starch Glycolate Market by 2035?

<p>The Sodium Starch Glycolate Market is projected to reach a valuation of 107.92 USD Million by 2035.</p>

What was the market valuation of Sodium Starch Glycolate in 2024?

<p>In 2024, the Sodium Starch Glycolate Market was valued at 19.01 USD Million.</p>

What is the expected CAGR for the Sodium Starch Glycolate Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Sodium Starch Glycolate Market during the forecast period 2025 - 2035 is 17.1%.</p>

Which application segment had the highest valuation in 2024?

<p>In 2024, the Pharmaceuticals application segment had the highest valuation at 7.61 USD Million.</p>

What are the key players in the Sodium Starch Glycolate Market?

<p>Key players in the Sodium Starch Glycolate Market include Ashland, Roquette Freres, JRS PHARMA, and Shree Renuka Sugars.</p>

How does the Food Industry segment perform in terms of valuation?

The Food Industry segment was valued at 5.7 USD Million in 2024 and is expected to grow significantly.

What was the valuation of the Granulation end-use segment in 2024?

The Granulation end-use segment was valued at 6.0 USD Million in 2024.

Which formulation type is projected to have the highest growth in the Sodium Starch Glycolate Market?

The Immediate Release formulation type had a valuation of 7.61 USD Million in 2024 and is likely to continue its growth.

What is the valuation of the Modified Starch source segment in 2024?

The Modified Starch source segment was valued at 7.0 USD Million in 2024.

What functionality segment is expected to dominate the market?

The Disintegrant functionality segment was valued at 7.61 USD Million in 2024 and is expected to maintain its dominance.

Market Summary

As per MRFR analysis, the Sodium Starch Glycolate Market Size was estimated at 19.01 USD Million in 2024. The Sodium Starch Glycolate industry is projected to grow from 22.26 USD Million in 2025 to 107.92 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 17.1% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Sodium Starch Glycolate Market is poised for substantial growth driven by diverse applications and evolving consumer preferences.

  • The market experiences rising demand in pharmaceuticals, particularly in tablet formulation, which remains the largest segment.
  • Asia-Pacific emerges as the fastest-growing region, reflecting a notable expansion in food applications and clean label products.
  • The food industry is witnessing rapid growth, with sodium starch glycolate increasingly utilized in capsule formulation.
  • Key market drivers include the rising demand in nutraceuticals and regulatory support for pharmaceutical applications.

Market Size & Forecast

2024 Market Size 19.01 (USD Million)
2035 Market Size 107.92 (USD Million)
CAGR (2025 - 2035) 17.1%
Largest Regional Market Share in 2024 North America

Major Players

Ashland (US), Roquette Freres (FR), JRS PHarma (DE), Shin-Etsu Chemical (JP), Mingtai Chemical (CN), Sodium Starch Glycolate Co. (IN), Liaoning Daxin Pharmaceutical (CN), Huzhou Zhenhua Chemical (CN)

Market Trends

The Sodium Starch Glycolate Market is currently experiencing notable growth, driven by its increasing application in the pharmaceutical sector as a disintegrant in tablet formulations. This compound, derived from starch, is valued for its ability to enhance the dissolution rate of active ingredients, thereby improving bioavailability. As the demand for effective drug delivery systems rises, manufacturers are focusing on developing innovative formulations that incorporate Sodium Starch Glycolate. Furthermore, the rising trend of personalized medicine is likely to propel the market forward, as tailored therapies often require specialized excipients to ensure optimal performance. In addition to pharmaceuticals, the Sodium Starch Glycolate Market is witnessing expansion in the food industry, where it serves as a thickening agent and stabilizer. The growing consumer preference for clean-label products is prompting food manufacturers to seek natural and safe additives, positioning Sodium Starch Glycolate as a favorable option. Moreover, the increasing awareness regarding health and wellness is influencing product formulations, leading to a surge in demand for Sodium Starch Glycolate in various food applications. Overall, the market appears poised for continued growth, driven by diverse applications and evolving consumer preferences.

Rising Demand in Pharmaceuticals

The Sodium Starch Glycolate Market is seeing heightened interest from pharmaceutical companies, as this excipient plays a crucial role in enhancing drug formulations. Its ability to improve the disintegration and dissolution of tablets is particularly appealing, especially in the context of developing more effective medications.

Expansion in Food Applications

There is a growing trend of utilizing Sodium Starch Glycolate in the food industry, where it is employed as a thickening and stabilizing agent. This shift is largely influenced by consumer demand for natural ingredients, prompting food manufacturers to incorporate this compound into their products.

Focus on Clean Label Products

The Sodium Starch Glycolate Market is benefiting from the increasing consumer preference for clean label products. As health-conscious consumers seek transparency in ingredient lists, manufacturers are likely to adopt Sodium Starch Glycolate due to its natural origins and safety profile.

Sodium Starch Glycolate Market Market Drivers

Market Growth Projections

The Global Sodium Starch Glycolate Market Industry is projected to experience substantial growth in the coming years. With a market valuation of 92.7 USD Million in 2024, it is anticipated to reach 174.2 USD Million by 2035. This growth trajectory indicates a robust demand for sodium starch glycolate, driven by its applications in pharmaceuticals and food industries. The expected CAGR of 5.9% from 2025 to 2035 further underscores the compound's potential in various sectors, reflecting its importance in enhancing product formulations and meeting consumer needs.

Rising Popularity in Food Industry

The Global Sodium Starch Glycolate Market Industry is also experiencing growth due to its application in the food sector, where it serves as a stabilizer and thickening agent. As consumer preferences shift towards processed foods that require improved texture and shelf-life, sodium starch glycolate becomes increasingly relevant. The compound's ability to enhance food quality while maintaining safety standards aligns with the global trend towards healthier eating. This trend is expected to contribute to the market's expansion, potentially leading to a valuation of 174.2 USD Million by 2035.

Regulatory Support and Safety Approvals

The Global Sodium Starch Glycolate Market Industry benefits from favorable regulatory frameworks that support the use of this compound in various applications. Regulatory bodies have recognized sodium starch glycolate as safe for use in pharmaceuticals and food products, which encourages manufacturers to incorporate it into their formulations. This regulatory backing not only enhances consumer confidence but also stimulates market growth. As safety standards continue to evolve, the industry is likely to see increased adoption of sodium starch glycolate, further solidifying its market position.

Technological Advancements in Production

Technological innovations in the production of sodium starch glycolate are driving efficiency and cost-effectiveness within the Global Sodium Starch Glycolate Market Industry. Advanced manufacturing techniques enable producers to optimize yield and reduce waste, which is crucial in meeting the growing demand. These advancements may also lead to improved product quality, enhancing the compound's performance in various applications. As production processes become more streamlined, the market is expected to grow at a CAGR of 5.9% from 2025 to 2035, reflecting the positive impact of technology on the industry.

Increasing Awareness of Health and Wellness

The Global Sodium Starch Glycolate Market Industry is influenced by a growing awareness of health and wellness among consumers. As individuals become more health-conscious, there is a rising demand for products that are not only effective but also safe and natural. Sodium starch glycolate, being derived from natural sources, aligns with this trend, making it an attractive ingredient for manufacturers in both the pharmaceutical and food sectors. This shift in consumer behavior is likely to propel market growth, as companies strive to meet the evolving preferences of health-oriented consumers.

Growing Demand in Pharmaceutical Applications

The Global Sodium Starch Glycolate Market Industry is witnessing a surge in demand primarily due to its extensive use as a disintegrant in pharmaceutical formulations. This compound enhances the dissolution rate of tablets and capsules, which is crucial for effective drug delivery. As the global pharmaceutical industry continues to expand, driven by increasing healthcare needs and innovations in drug development, the demand for sodium starch glycolate is projected to rise. In 2024, the market is valued at 92.7 USD Million, reflecting the compound's essential role in modern pharmaceuticals.

Market Segment Insights

By Application: Pharmaceuticals (Largest) vs. Cosmetics (Fastest-Growing)

<p>The Sodium Starch Glycolate Market exhibits significant variation across its application segments, with Pharmaceuticals commanding the largest share due to its extensive use as a disintegrant in drug formulations. As a key excipient, it plays a critical role in shaping the market dynamics, enforced by stringent regulatory standards that favor established products in this area. The Food Industry follows, leveraging Sodium Starch Glycolate for its thickening and stabilizing properties. Meanwhile, Cosmetics and Agriculture are gaining traction but still hold smaller market shares, focusing on enhanced product performance and consumer preference for natural ingredients.</p>

<p>Pharmaceuticals (Dominant) vs. Cosmetics (Emerging)</p>

<p>The Pharmaceuticals segment remains a dominant force in the Sodium Starch Glycolate Market, driven by its integral role in oral dosage forms where it aids tablet disintegration. Its established reputation and regulatory compliance create a robust demand. Conversely, the Cosmetics segment is emerging rapidly, fueled by the growing trend towards the use of natural and safe ingredients in beauty products. As consumers increasingly seek additives that provide both functionality and safety, the application of Sodium Starch Glycolate in skincare and personal care formulations positions it favorably as an innovative solution. This shift reflects broader consumer trends towards health and sustainability, allowing the Cosmetics segment to flourish.</p>

By End Use: Tablet Formulation (Largest) vs. Capsule Formulation (Fastest-Growing)

In the Sodium Starch Glycolate market, the end-use segment displays a diverse range of applications, with Tablet Formulation taking the lead in market share. This segment benefits from the increasing demand for solid dosage forms, which are preferred for their convenience and ease of consumption. Following closely, Capsule Formulation is emerging as a significant player, fueled by consumer preference for softgels and hard capsules that enhance bioavailability. Granulation and Coating are also noteworthy in this segment, albeit with smaller shares.

Tablet Formulation (Dominant) vs. Capsule Formulation (Emerging)

Tablet Formulation remains dominant in the Sodium Starch Glycolate market, primarily due to its widespread use in pharmaceuticals. This segment benefits from the formulation's ability to deliver active ingredients effectively while ensuring stability and controlled release. In contrast, Capsule Formulation is considered an emerging segment characterized by its growing popularity attributed to enhanced patient adherence and ease of swallowing. The versatility in design and customization of capsules caters to diverse therapeutic needs, contributing to its rapid growth in recent years.

By Formulation Type: Immediate Release (Largest) vs. Controlled Release (Fastest-Growing)

<p>In the Sodium Starch Glycolate market, the formulation type segment is characterized by three key variants: Immediate Release, Controlled Release, and Sustained Release. Currently, Immediate Release dominates the market, representing the largest share due to its widespread use in various pharmaceutical applications, including tablet and capsule formulations. Meanwhile, Controlled Release formulations are rapidly gaining traction, driven by an increasing demand for dosage forms that offer improved patient compliance and therapeutic efficacy.</p>

<p>Formulation Type: Immediate Release (Dominant) vs. Controlled Release (Emerging)</p>

<p>Immediate Release formulations leverage Sodium Starch Glycolate's unique properties to facilitate rapid disintegration and dissolution, making them a preferred choice for many <a href="https://www.marketresearchfuture.com/reports/drug-delivery-system-market-43638" target="_blank" title="drug delivery system">drug delivery systems</a>. This segment is characterized by its reliability and effectiveness in acute treatment scenarios. Conversely, Controlled Release formulations have emerged as a significant growth area, appealing to pharmaceutical developers seeking innovative solutions that enhance drug efficacy and duration of action. These formulations address critical patient needs by minimizing dosing frequency and optimizing therapeutic outcomes, aligning with market trends focusing on patient-centered treatments.</p>

By Source: Natural Starch (Largest) vs. Modified Starch (Fastest-Growing)

<p>In the Sodium Starch Glycolate Market, the source segment is delineated primarily into Natural Starch, Modified Starch, and Synthetic Starch. Natural Starch maintains a significant market share, appealing due to its organic appeal and perceived health benefits. Modified Starch is also notable, increasingly preferred for its versatility and enhanced properties in pharmaceutical applications. Synthetic Starch, while smaller in market share, serves niche applications but is progressively gaining traction.</p>

<p>Natural Starch (Dominant) vs. Modified Starch (Emerging)</p>

<p>Natural Starch stands as the dominant player in the Sodium Starch Glycolate Market, known for its natural composition that aligns with consumer preferences towards clean-label products. It is widely used in formulations due to its favorable regulatory standing and consumer acceptance. Meanwhile, Modified Starch is emerging rapidly as a key player, driven by innovations that enhance its properties, such as improved binding and disintegration capabilities. Its adaptability in various pharmaceutical applications is contributing to its growth, making it a focal point for manufacturers looking to reformulate products without sacrificing performance.</p>

By Functionality: Disintegrant (Largest) vs. Binder (Fastest-Growing)

<p>In the Sodium Starch Glycolate Market, the functionality segment exhibits a diverse distribution among its primary values. Disintegrants hold the largest share, being vital for facilitating the breakdown of tablets and capsules. Binders and thickening agents also contribute significantly to the market, although they occupy smaller slices of the market share pie. Binders are essential for enhancing the cohesiveness of pharmaceutical formulations, while thickening agents often find their utility in varied applications, leading to a competitive yet balanced market environment. The growth trends within this functionality segment are largely driven by the increasing demand for efficient pharmaceutical formulations. Disintegrants are witnessing steady demand due to their essential role in drug delivery mechanisms, whereas binders are experiencing rapid growth as manufacturers prioritize product stability and formulation flexibility. The surge in the overall pharmaceutical industry and the evolution of drug formulations directly influences the adoption of these functionalities, positioning them favorably for future expansion within the market.</p>

<p>Disintegrant (Dominant) vs. Binder (Emerging)</p>

<p>In the Sodium Starch Glycolate Market, Disintegrants are recognized as the dominant functionality due to their critical role in the dissolution of oral dosage forms, ensuring that active ingredients are readily available for absorption. Their proven effectiveness in enhancing bioavailability has solidified their position, making them a staple in pharmaceutical manufacturing. On the other hand, Binders represent an emerging segment, increasingly favored for their ability to improve the integrity and handling properties of formulations. The ongoing innovation in binder compositions and the growing trends towards tailored drug delivery systems reflect their evolving importance. Together, these functionalities are pivotal, with Disintegrants supporting traditional formulation needs and Binders responding to newer market demands.</p>

Get more detailed insights about Sodium Starch Glycolate Market Research Report - Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America is poised to maintain its leadership in the Sodium Starch Glycolate market, holding a significant share of 9.5 in 2024. The region's growth is driven by increasing demand in the pharmaceutical and food industries, alongside stringent regulatory frameworks that promote quality and safety. The presence of advanced manufacturing facilities and a robust supply chain further catalyze market expansion. The United States stands out as the leading country, hosting major players like Ashland and JRS Pharma. The competitive landscape is characterized by innovation and strategic partnerships, enabling companies to enhance product offerings. With a focus on research and development, North American firms are well-positioned to meet evolving consumer needs and regulatory standards.

Europe : Emerging Market with Potential

Europe is witnessing a growing interest in Sodium Starch Glycolate, with a market size of 4.5 in 2024. The region benefits from a strong regulatory environment that encourages the use of excipients in pharmaceuticals, driving demand. Additionally, the increasing focus on natural and plant-based ingredients aligns with consumer preferences, further propelling market growth. Germany and France are key players in this market, with companies like Roquette Freres and JRS Pharma leading the charge. The competitive landscape is marked by innovation and sustainability initiatives, as firms strive to meet both regulatory requirements and consumer expectations. The European market is expected to continue evolving, driven by advancements in technology and product development.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is emerging as a significant player in the Sodium Starch Glycolate market, with a size of 3.5 in 2024. The region's growth is fueled by increasing pharmaceutical production and a rising demand for excipients in drug formulations. Additionally, favorable government policies and investments in healthcare infrastructure are expected to further enhance market dynamics. China and India are at the forefront of this growth, with companies like Mingtai Chemical and Sodium Starch Glycolate Co. leading the market. The competitive landscape is characterized by a mix of local and international players, all vying for market share. As the region continues to develop, the focus on quality and compliance with international standards will be crucial for sustained growth.

Middle East and Africa : Emerging Market Opportunities

The Middle East and Africa region is gradually emerging in the Sodium Starch Glycolate market, with a size of 1.51 in 2024. The growth is driven by increasing pharmaceutical manufacturing and a rising awareness of the importance of excipients in drug formulations. Additionally, government initiatives aimed at improving healthcare infrastructure are expected to support market expansion. Countries like South Africa and the UAE are leading the charge, with a growing number of local manufacturers entering the market. The competitive landscape is evolving, with both regional and international players seeking to establish a foothold. As the market matures, the focus on quality and regulatory compliance will be essential for attracting investment and fostering growth.

Key Players and Competitive Insights

The Sodium Starch Glycolate Market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Ashland (US), Roquette Freres (FR), and JRS PHarma (DE) are actively pursuing growth through various operational strategies. Ashland (US) focuses on enhancing its product portfolio through research and development, aiming to meet the evolving demands of the pharmaceutical industry. Meanwhile, Roquette Freres (FR) emphasizes sustainability in its operations, aligning its product offerings with environmentally friendly practices. JRS Pharma (DE) appears to be concentrating on expanding its global footprint, particularly in emerging markets, thereby enhancing its competitive positioning. Collectively, these strategies indicate a market that is not only competitive but also responsive to the changing dynamics of consumer preferences and regulatory requirements.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach is particularly relevant in a market that is moderately fragmented, where the influence of key players is significant but not overwhelming. The collective actions of these companies suggest a trend towards greater collaboration and efficiency, which may enhance overall market stability and growth potential.

In November Ashland (US) announced a strategic partnership with a leading pharmaceutical manufacturer to co-develop innovative formulations utilizing Sodium Starch Glycolate. This collaboration is expected to leverage Ashland's expertise in excipients and the partner's market reach, potentially leading to enhanced product offerings and increased market share. The strategic importance of this partnership lies in its potential to accelerate product development cycles and improve customer satisfaction through tailored solutions.

In October Roquette Freres (FR) launched a new line of Sodium Starch Glycolate products designed specifically for the nutraceutical sector. This move is indicative of Roquette's strategy to diversify its product applications and cater to the growing demand for health supplements. By targeting this niche market, Roquette may enhance its competitive edge and capitalize on the increasing consumer focus on health and wellness.

In September JRS Pharma (DE) expanded its manufacturing capabilities in Asia, aiming to better serve the regional market. This expansion is strategically significant as it positions JRS to respond more effectively to local demand and reduce logistical challenges. The investment in local production facilities may also lead to cost efficiencies and improved supply chain reliability, which are critical in maintaining competitiveness in the Sodium Starch Glycolate Market.

As of December the competitive trends in the Sodium Starch Glycolate Market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing operational efficiencies. Looking ahead, it is likely that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift may redefine the competitive landscape, compelling companies to adapt and innovate continuously.

Key Companies in the Sodium Starch Glycolate Market include

Industry Developments

DEF pharma's Primojel, an SSG, is commonly utilized in the production of tablets and capsules. The presence of large biotech and pharmaceutical companies in the United States is anticipated to boost demand for the product. The Sodium Starch Glycolate Market is growing due to increased demand for adhesives from the automotive and packaging industries. Roquette Co. announced the development of a new SSG product for the cosmetics sector under the brand Beauty by Roquette. Modified starches, which are utilized in adhesives, have also been introduced. Globally, rising consumer expenditure on food is likely to propel the Sodium Starch Glycolate Market forward.

Intended Audience

    • Sodium starch glycolate Manufacturers
    • Traders and distributors of sodium starch glycolate
    • Research and development institutes
    • Potential investors
    • Raw material suppliers
    • Nationalized laboratory

Future Outlook

Sodium Starch Glycolate Market Future Outlook

The Sodium Starch Glycolate Market is projected to grow at a 17.1% CAGR from 2025 to 2035, driven by increasing demand in pharmaceuticals and food industries.

New opportunities lie in:

  • Expansion into emerging markets with tailored formulations.
  • Development of eco-friendly production processes to attract sustainability-focused clients.
  • Strategic partnerships with pharmaceutical companies for innovative drug delivery systems.

By 2035, the Sodium Starch Glycolate Market is expected to achieve robust growth and enhanced market presence.

Market Segmentation

Sodium Starch Glycolate Market Source Outlook

  • Natural Starch
  • Modified Starch
  • Synthetic Starch

Sodium Starch Glycolate Market End Use Outlook

  • Tablet Formulation
  • Capsule Formulation
  • Granulation
  • Coating

Sodium Starch Glycolate Market Application Outlook

  • Pharmaceuticals
  • Food Industry
  • Cosmetics
  • Agriculture

Sodium Starch Glycolate Market Functionality Outlook

  • Disintegrant
  • Binder
  • Thickening Agent
  • Stabilizer

Sodium Starch Glycolate Market Formulation Type Outlook

  • Immediate Release
  • Controlled Release
  • Sustained Release

Report Scope

MARKET SIZE 2024 19.01(USD Million)
MARKET SIZE 2025 22.26(USD Million)
MARKET SIZE 2035 107.92(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 17.1% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Ashland (US), Roquette Freres (FR), JRS PHarma (DE), Shin-Etsu Chemical (JP), Mingtai Chemical (CN), Sodium Starch Glycolate Co. (IN), Liaoning Daxin Pharmaceutical (CN), Huzhou Zhenhua Chemical (CN)
Segments Covered Application, End Use, Functionality, Formulation Type, Source
Key Market Opportunities Growing demand for excipients in pharmaceuticals drives innovation in the Sodium Starch Glycolate Market.
Key Market Dynamics Rising demand for sodium starch glycolate in pharmaceuticals drives innovation and competition among manufacturers.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Sodium Starch Glycolate Market by 2035?

<p>The Sodium Starch Glycolate Market is projected to reach a valuation of 107.92 USD Million by 2035.</p>

What was the market valuation of Sodium Starch Glycolate in 2024?

<p>In 2024, the Sodium Starch Glycolate Market was valued at 19.01 USD Million.</p>

What is the expected CAGR for the Sodium Starch Glycolate Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Sodium Starch Glycolate Market during the forecast period 2025 - 2035 is 17.1%.</p>

Which application segment had the highest valuation in 2024?

<p>In 2024, the Pharmaceuticals application segment had the highest valuation at 7.61 USD Million.</p>

What are the key players in the Sodium Starch Glycolate Market?

<p>Key players in the Sodium Starch Glycolate Market include Ashland, Roquette Freres, JRS PHARMA, and Shree Renuka Sugars.</p>

How does the Food Industry segment perform in terms of valuation?

The Food Industry segment was valued at 5.7 USD Million in 2024 and is expected to grow significantly.

What was the valuation of the Granulation end-use segment in 2024?

The Granulation end-use segment was valued at 6.0 USD Million in 2024.

Which formulation type is projected to have the highest growth in the Sodium Starch Glycolate Market?

The Immediate Release formulation type had a valuation of 7.61 USD Million in 2024 and is likely to continue its growth.

What is the valuation of the Modified Starch source segment in 2024?

The Modified Starch source segment was valued at 7.0 USD Million in 2024.

What functionality segment is expected to dominate the market?

The Disintegrant functionality segment was valued at 7.61 USD Million in 2024 and is expected to maintain its dominance.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Chemicals and Materials, BY Application (USD Million)
    2. | | 4.1.1 Pharmaceuticals
    3. | | 4.1.2 Food Industry
    4. | | 4.1.3 Cosmetics
    5. | | 4.1.4 Agriculture
    6. | 4.2 Chemicals and Materials, BY End Use (USD Million)
    7. | | 4.2.1 Tablet Formulation
    8. | | 4.2.2 Capsule Formulation
    9. | | 4.2.3 Granulation
    10. | | 4.2.4 Coating
    11. | 4.3 Chemicals and Materials, BY Formulation Type (USD Million)
    12. | | 4.3.1 Immediate Release
    13. | | 4.3.2 Controlled Release
    14. | | 4.3.3 Sustained Release
    15. | 4.4 Chemicals and Materials, BY Source (USD Million)
    16. | | 4.4.1 Natural Starch
    17. | | 4.4.2 Modified Starch
    18. | | 4.4.3 Synthetic Starch
    19. | 4.5 Chemicals and Materials, BY Functionality (USD Million)
    20. | | 4.5.1 Disintegrant
    21. | | 4.5.2 Binder
    22. | | 4.5.3 Thickening Agent
    23. | 4.6 Chemicals and Materials, BY Region (USD Million)
    24. | | 4.6.1 North America
    25. | | | 4.6.1.1 US
    26. | | | 4.6.1.2 Canada
    27. | | 4.6.2 Europe
    28. | | | 4.6.2.1 Germany
    29. | | | 4.6.2.2 UK
    30. | | | 4.6.2.3 France
    31. | | | 4.6.2.4 Russia
    32. | | | 4.6.2.5 Italy
    33. | | | 4.6.2.6 Spain
    34. | | | 4.6.2.7 Rest of Europe
    35. | | 4.6.3 APAC
    36. | | | 4.6.3.1 China
    37. | | | 4.6.3.2 India
    38. | | | 4.6.3.3 Japan
    39. | | | 4.6.3.4 South Korea
    40. | | | 4.6.3.5 Malaysia
    41. | | | 4.6.3.6 Thailand
    42. | | | 4.6.3.7 Indonesia
    43. | | | 4.6.3.8 Rest of APAC
    44. | | 4.6.4 South America
    45. | | | 4.6.4.1 Brazil
    46. | | | 4.6.4.2 Mexico
    47. | | | 4.6.4.3 Argentina
    48. | | | 4.6.4.4 Rest of South America
    49. | | 4.6.5 MEA
    50. | | | 4.6.5.1 GCC Countries
    51. | | | 4.6.5.2 South Africa
    52. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Chemicals and Materials
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Ashland (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Roquette Freres (FR)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 JRS PHARMA (DE)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Shree Renuka Sugars (IN)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Sodium Starch Glycolate Co. (JP)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Siegfried AG (CH)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Liaoning Huaxing Chemical Industry (CN)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Zhejiang Jianfeng Chemical (CN)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | 5.3 Appendix
    65. | | 5.3.1 References
    66. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY END USE
    5. | 6.5 US MARKET ANALYSIS BY FORMULATION TYPE
    6. | 6.6 US MARKET ANALYSIS BY SOURCE
    7. | 6.7 US MARKET ANALYSIS BY FUNCTIONALITY
    8. | 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. | 6.9 CANADA MARKET ANALYSIS BY END USE
    10. | 6.10 CANADA MARKET ANALYSIS BY FORMULATION TYPE
    11. | 6.11 CANADA MARKET ANALYSIS BY SOURCE
    12. | 6.12 CANADA MARKET ANALYSIS BY FUNCTIONALITY
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. | 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. | 6.16 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
    17. | 6.17 GERMANY MARKET ANALYSIS BY SOURCE
    18. | 6.18 GERMANY MARKET ANALYSIS BY FUNCTIONALITY
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 UK MARKET ANALYSIS BY END USE
    21. | 6.21 UK MARKET ANALYSIS BY FORMULATION TYPE
    22. | 6.22 UK MARKET ANALYSIS BY SOURCE
    23. | 6.23 UK MARKET ANALYSIS BY FUNCTIONALITY
    24. | 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. | 6.25 FRANCE MARKET ANALYSIS BY END USE
    26. | 6.26 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
    27. | 6.27 FRANCE MARKET ANALYSIS BY SOURCE
    28. | 6.28 FRANCE MARKET ANALYSIS BY FUNCTIONALITY
    29. | 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. | 6.30 RUSSIA MARKET ANALYSIS BY END USE
    31. | 6.31 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
    32. | 6.32 RUSSIA MARKET ANALYSIS BY SOURCE
    33. | 6.33 RUSSIA MARKET ANALYSIS BY FUNCTIONALITY
    34. | 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. | 6.35 ITALY MARKET ANALYSIS BY END USE
    36. | 6.36 ITALY MARKET ANALYSIS BY FORMULATION TYPE
    37. | 6.37 ITALY MARKET ANALYSIS BY SOURCE
    38. | 6.38 ITALY MARKET ANALYSIS BY FUNCTIONALITY
    39. | 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. | 6.40 SPAIN MARKET ANALYSIS BY END USE
    41. | 6.41 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
    42. | 6.42 SPAIN MARKET ANALYSIS BY SOURCE
    43. | 6.43 SPAIN MARKET ANALYSIS BY FUNCTIONALITY
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY SOURCE
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY FUNCTIONALITY
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. | 6.51 CHINA MARKET ANALYSIS BY END USE
    52. | 6.52 CHINA MARKET ANALYSIS BY FORMULATION TYPE
    53. | 6.53 CHINA MARKET ANALYSIS BY SOURCE
    54. | 6.54 CHINA MARKET ANALYSIS BY FUNCTIONALITY
    55. | 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. | 6.56 INDIA MARKET ANALYSIS BY END USE
    57. | 6.57 INDIA MARKET ANALYSIS BY FORMULATION TYPE
    58. | 6.58 INDIA MARKET ANALYSIS BY SOURCE
    59. | 6.59 INDIA MARKET ANALYSIS BY FUNCTIONALITY
    60. | 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. | 6.61 JAPAN MARKET ANALYSIS BY END USE
    62. | 6.62 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
    63. | 6.63 JAPAN MARKET ANALYSIS BY SOURCE
    64. | 6.64 JAPAN MARKET ANALYSIS BY FUNCTIONALITY
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY SOURCE
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY FUNCTIONALITY
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY END USE
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY SOURCE
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY FUNCTIONALITY
    75. | 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. | 6.76 THAILAND MARKET ANALYSIS BY END USE
    77. | 6.77 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
    78. | 6.78 THAILAND MARKET ANALYSIS BY SOURCE
    79. | 6.79 THAILAND MARKET ANALYSIS BY FUNCTIONALITY
    80. | 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. | 6.81 INDONESIA MARKET ANALYSIS BY END USE
    82. | 6.82 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
    83. | 6.83 INDONESIA MARKET ANALYSIS BY SOURCE
    84. | 6.84 INDONESIA MARKET ANALYSIS BY FUNCTIONALITY
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY END USE
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY SOURCE
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY FUNCTIONALITY
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. | 6.92 BRAZIL MARKET ANALYSIS BY END USE
    93. | 6.93 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
    94. | 6.94 BRAZIL MARKET ANALYSIS BY SOURCE
    95. | 6.95 BRAZIL MARKET ANALYSIS BY FUNCTIONALITY
    96. | 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. | 6.97 MEXICO MARKET ANALYSIS BY END USE
    98. | 6.98 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
    99. | 6.99 MEXICO MARKET ANALYSIS BY SOURCE
    100. | 6.100 MEXICO MARKET ANALYSIS BY FUNCTIONALITY
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY END USE
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY SOURCE
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY FUNCTIONALITY
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SOURCE
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTIONALITY
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY SOURCE
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY FUNCTIONALITY
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY SOURCE
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY FUNCTIONALITY
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY END USE
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY SOURCE
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY FUNCTIONALITY
    127. | 6.127 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    130. | 6.130 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    132. | 6.132 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    133. | 6.133 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
    134. | 6.134 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
    135. | 6.135 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
    136. | 6.136 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
    137. | 6.137 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 (% SHARE)
    138. | 6.138 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
    139. | 6.139 CHEMICALS AND MATERIALS, BY SOURCE, 2024 (% SHARE)
    140. | 6.140 CHEMICALS AND MATERIALS, BY SOURCE, 2024 TO 2035 (USD Million)
    141. | 6.141 CHEMICALS AND MATERIALS, BY FUNCTIONALITY, 2024 (% SHARE)
    142. | 6.142 CHEMICALS AND MATERIALS, BY FUNCTIONALITY, 2024 TO 2035 (USD Million)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
    5. | | 7.2.2 BY END USE, 2025-2035 (USD Million)
    6. | | 7.2.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    7. | | 7.2.4 BY SOURCE, 2025-2035 (USD Million)
    8. | | 7.2.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
    11. | | 7.3.2 BY END USE, 2025-2035 (USD Million)
    12. | | 7.3.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    13. | | 7.3.4 BY SOURCE, 2025-2035 (USD Million)
    14. | | 7.3.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
    17. | | 7.4.2 BY END USE, 2025-2035 (USD Million)
    18. | | 7.4.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    19. | | 7.4.4 BY SOURCE, 2025-2035 (USD Million)
    20. | | 7.4.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
    23. | | 7.5.2 BY END USE, 2025-2035 (USD Million)
    24. | | 7.5.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    25. | | 7.5.4 BY SOURCE, 2025-2035 (USD Million)
    26. | | 7.5.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
    29. | | 7.6.2 BY END USE, 2025-2035 (USD Million)
    30. | | 7.6.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    31. | | 7.6.4 BY SOURCE, 2025-2035 (USD Million)
    32. | | 7.6.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
    35. | | 7.7.2 BY END USE, 2025-2035 (USD Million)
    36. | | 7.7.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    37. | | 7.7.4 BY SOURCE, 2025-2035 (USD Million)
    38. | | 7.7.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
    41. | | 7.8.2 BY END USE, 2025-2035 (USD Million)
    42. | | 7.8.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    43. | | 7.8.4 BY SOURCE, 2025-2035 (USD Million)
    44. | | 7.8.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
    47. | | 7.9.2 BY END USE, 2025-2035 (USD Million)
    48. | | 7.9.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    49. | | 7.9.4 BY SOURCE, 2025-2035 (USD Million)
    50. | | 7.9.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
    53. | | 7.10.2 BY END USE, 2025-2035 (USD Million)
    54. | | 7.10.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    55. | | 7.10.4 BY SOURCE, 2025-2035 (USD Million)
    56. | | 7.10.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
    59. | | 7.11.2 BY END USE, 2025-2035 (USD Million)
    60. | | 7.11.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    61. | | 7.11.4 BY SOURCE, 2025-2035 (USD Million)
    62. | | 7.11.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
    65. | | 7.12.2 BY END USE, 2025-2035 (USD Million)
    66. | | 7.12.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    67. | | 7.12.4 BY SOURCE, 2025-2035 (USD Million)
    68. | | 7.12.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
    71. | | 7.13.2 BY END USE, 2025-2035 (USD Million)
    72. | | 7.13.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    73. | | 7.13.4 BY SOURCE, 2025-2035 (USD Million)
    74. | | 7.13.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
    77. | | 7.14.2 BY END USE, 2025-2035 (USD Million)
    78. | | 7.14.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    79. | | 7.14.4 BY SOURCE, 2025-2035 (USD Million)
    80. | | 7.14.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
    83. | | 7.15.2 BY END USE, 2025-2035 (USD Million)
    84. | | 7.15.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    85. | | 7.15.4 BY SOURCE, 2025-2035 (USD Million)
    86. | | 7.15.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
    89. | | 7.16.2 BY END USE, 2025-2035 (USD Million)
    90. | | 7.16.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    91. | | 7.16.4 BY SOURCE, 2025-2035 (USD Million)
    92. | | 7.16.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
    95. | | 7.17.2 BY END USE, 2025-2035 (USD Million)
    96. | | 7.17.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    97. | | 7.17.4 BY SOURCE, 2025-2035 (USD Million)
    98. | | 7.17.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
    101. | | 7.18.2 BY END USE, 2025-2035 (USD Million)
    102. | | 7.18.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    103. | | 7.18.4 BY SOURCE, 2025-2035 (USD Million)
    104. | | 7.18.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
    107. | | 7.19.2 BY END USE, 2025-2035 (USD Million)
    108. | | 7.19.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    109. | | 7.19.4 BY SOURCE, 2025-2035 (USD Million)
    110. | | 7.19.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
    113. | | 7.20.2 BY END USE, 2025-2035 (USD Million)
    114. | | 7.20.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    115. | | 7.20.4 BY SOURCE, 2025-2035 (USD Million)
    116. | | 7.20.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
    119. | | 7.21.2 BY END USE, 2025-2035 (USD Million)
    120. | | 7.21.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    121. | | 7.21.4 BY SOURCE, 2025-2035 (USD Million)
    122. | | 7.21.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
    125. | | 7.22.2 BY END USE, 2025-2035 (USD Million)
    126. | | 7.22.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    127. | | 7.22.4 BY SOURCE, 2025-2035 (USD Million)
    128. | | 7.22.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
    131. | | 7.23.2 BY END USE, 2025-2035 (USD Million)
    132. | | 7.23.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    133. | | 7.23.4 BY SOURCE, 2025-2035 (USD Million)
    134. | | 7.23.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
    137. | | 7.24.2 BY END USE, 2025-2035 (USD Million)
    138. | | 7.24.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    139. | | 7.24.4 BY SOURCE, 2025-2035 (USD Million)
    140. | | 7.24.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
    143. | | 7.25.2 BY END USE, 2025-2035 (USD Million)
    144. | | 7.25.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    145. | | 7.25.4 BY SOURCE, 2025-2035 (USD Million)
    146. | | 7.25.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
    149. | | 7.26.2 BY END USE, 2025-2035 (USD Million)
    150. | | 7.26.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    151. | | 7.26.4 BY SOURCE, 2025-2035 (USD Million)
    152. | | 7.26.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
    155. | | 7.27.2 BY END USE, 2025-2035 (USD Million)
    156. | | 7.27.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    157. | | 7.27.4 BY SOURCE, 2025-2035 (USD Million)
    158. | | 7.27.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
    161. | | 7.28.2 BY END USE, 2025-2035 (USD Million)
    162. | | 7.28.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    163. | | 7.28.4 BY SOURCE, 2025-2035 (USD Million)
    164. | | 7.28.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
    167. | | 7.29.2 BY END USE, 2025-2035 (USD Million)
    168. | | 7.29.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    169. | | 7.29.4 BY SOURCE, 2025-2035 (USD Million)
    170. | | 7.29.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
    173. | | 7.30.2 BY END USE, 2025-2035 (USD Million)
    174. | | 7.30.3 BY FORMULATION TYPE, 2025-2035 (USD Million)
    175. | | 7.30.4 BY SOURCE, 2025-2035 (USD Million)
    176. | | 7.30.5 BY FUNCTIONALITY, 2025-2035 (USD Million)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2025-2035)

  • Pharmaceuticals
  • Food Industry
  • Cosmetics
  • Agriculture

Chemicals and Materials By End Use (USD Million, 2025-2035)

  • Tablet Formulation
  • Capsule Formulation
  • Granulation
  • Coating

Chemicals and Materials By Formulation Type (USD Million, 2025-2035)

  • Immediate Release
  • Controlled Release
  • Sustained Release

Chemicals and Materials By Source (USD Million, 2025-2035)

  • Natural Starch
  • Modified Starch
  • Synthetic Starch

Chemicals and Materials By Functionality (USD Million, 2025-2035)

  • Disintegrant
  • Binder
  • Thickening Agent
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓